December 05-06, 2022
Dubai, UAE
Felicitations!
Following the successful completion of Pharmaceutics 2022, the Organizing Committee is pleased to welcome you to the 5th Global Summit on Pharmaceuticals, Drug Discovery and Nanoscience.which after a careful consideration is decided to take place on the city of Dubai, UAE on December 05-06, 2022.
The past two years with the pandemic has certainly affected the scientific community in terms of networking and with the number of vaccinations increasing over a period and also decline in COVID cases around the world, the committee decided that it would be perfect for the attendees to be at the NanoPharmaceutics 2022 and no better place than Dubai is perfect for such occasion!
The conference revolves around the theme of discussing the scope and prospects of Pharmaceutics and Nanomedicine and how they can influence the current situation and beyond.
NanoPharmaceutics 2022 intends to discuss the advancements and innovations that are made in the domain of Pharmaceutical sector and how nanoscience can influence such improvements that are being made in the domain of Pharmaceuticals.
With the pandemic still fresh in our minds, NanoPharmaceutics 2022 hopes all attendees will have a great time by delivering quality sessions, indulging the world's best pharma staff and making sure they have a good time. We create positive memories and a new start for participants in this event.
The Conference intends to discuss various aspects of pharmaceutics, drug discovery and nanoscience domain and some of the session includes,
Track 01: Pharmaceutics
Pharmaceutics are one of the primary factors for developing a drug as it involves in converting a new chemical entity to a completely novel product which can be used for the treatment of any particular disease. Pharmaceutics is one of the major components that is taken into consideration while developing a novel drug as it primarily involves in predicting the perfect amount of dosage that is necessary for an individual to get treated for the specific condition.
Track 02: Nanoscience and Nanotechnology
Nanotechnology is one of the most well-recognized and well utilized domains across various fields which provide a positive solution at a Nano-level for every product. Nanomedicine is one of the currently developing domains of nanotechnology sector in which the nano-based solutions are being developed for developing medicinal devices, sensors and much more. Other than being involved in developing material-based products, some of the nano-based solutions are being utilized on the developments of drug particles and much more. Toxicity and other disadvantages comes into place as a result of it but it is one of the more advanced and fast-growing solutions in the domain of pharmaceutics.
Track 03: Drug Delivery Systems
For a drug that is being developed and to be introduced on to a market, some of the pre-determining factors for a drug to be taken into account are the mode of delivery in which the drug is being introduced to an individual and the way the lead particle has its influence in reducing the damage caused by the virus and helps in aiding the betterment of the individual. These therapeutics agents that are being designed have the potential to tackle any complications that occur within the human body and the type of delivery determines the efficacy and activity of such compounds.
Track 04: Artificial Intelligence and Pharmaceutics
Artificial Intelligence is one of the current advanced ways of indulging machine level solutions to the existing problems which are difficult or takes much time while tackling through natural means. In recent years, Artificial Intelligence has found its way on the Pharmaceutical sector and providing cutting-edge solutions to some of the leading pharmaceutical companies around the world.
Track 05: Bionanomaterials
Biology is one of the vast domains in the sector of general science which helps in understanding the nature of human and animal system as to how they will function as a whole and helps in understanding the basic aspect of living. Bionanomaterials is one of the promising and advanced research innovations in the domain of Pharmaceutics which involves the utilization of biological materials such as cells and nucleic acids to develop them to an organic or inorganic material which has a wide variety of properties in tackling some complex conditions.
Track 06: Pharmaceutical Nanotechnology
Nanotechnology is one of the most intriguing yet exiting sectors which seem to find its place on any sector from medicine to industry. The involvement of nanotechnology on the field of medicine is one of the complicated challenges for the researchers as the results of involving nanotechnology in pharmaceuticals were tough in the beginning. However, in recent years, nanotechnology has taken the world of pharmaceutics by storm by providing quality solutions to some of the difficulties which are faced by the industries over the years.
Track 07: Pharmaceutical Formulation
Drug formulation is one of the key factors and the first primary step that is to be taken into consideration as it determines the overall composition of the how the drug is needed to be made so that it can perform the activity which it needs to perform. As the drugs are to be taken by humans during the clinical trials the drug is needed to be designed in such a way that it won’t cause any damages to the system. The process involves the usage of Active Pharmaceutical Ingredient (API) which is the novel product that is set to treat the condition is added along with some excipients, which are highly inactive and helps in aiding the API to reach the potential treatment place before the API gets wasted on places other than the site of damage.
Track 08: Pharmaceuticals and Vaccines
Vaccines are chemical or biological compounds which are given to individuals to enact an immune response against a certain disease. Vaccines help in activating the immune response by the cells against particular diseases so if they were to attack the system again, the human system will respond to the vaccines at a faster rate and eliminate the threat before it develops and takes over the human system. With the pharmaceutical companies were less interested in developing vaccines during the late 2018’s, the threat of COVID-19 enabled every industry to develop a novel vaccine as it is a disease that has never been tackled before. Major Pharmaceutical companies have started to put more effort on developing vaccines and set to take their place as one of the pioneers in this domain
Track 09: Radiopharmaceuticals
Radiopharmaceuticals are one in which radioactive agents are used to diagnose or to treat a particular disease condition. The usage of radioactive agents for treating any condition seems complex and may cause some damages to the system however, if they are to be used on smaller amount for diagnostic purposes, they are considered to be safe and is they are to be used to treatment, larger amount of radioactive materials are needed and thereby causing some lasting side-effects to the system.
Track 10: Pharmacology
Pharmacology defines the interaction between the chemicals and the human system and how it influences treating the disease. The pharmacology studies help in understanding the optimal level of drug composition needed to treat disease and the way the drug needs to be designed so it may be enough to treat the complexion within the system. This is the major step that is to be followed before the production of the drugs on a larger scale.
Track 11: Pharmaceutical Biotechnology
Pharmaceutical biotechnology is a novel and innovative process in which the concept of Biotechnology is integrated with pharmaceutical studies to develop a novel and innovative drug product. The current market is filled with bio-tech-developed products (bio-formulations) such as vaccines, antibodies, nucleic acid products, etc. One of the major product developments that are derived through this domain involves removing and altering our own cells and directing our system to eliminate the disease. This method is found successful and now nearly 51% of the biotechnology-related solutions are used by health care and pharmaceutical domains.
Track 12: Pharmacokinetics
The science of drug movement is known as pharmacokinetics. Pharmacokinetics is one of the two major fields of study that comprise the scientific discipline of pharmacology. The application of pharmacokinetic principles to the safe and effective therapeutic management of drugs in an individual patient is referred to as clinical pharmacokinetics. Clinical pharmacokinetics involves improving the efficacy and lowering the toxicity of a patient's drug therapy. The discovery of strong correlations between drug concentrations and pharmacologic responses has enabled clinicians to apply pharmacokinetic principles to real-world patient situations. In pharmacokinetics, four phases are involved.
Track 13: Pharmacodynamics
Pharmacodynamics is the study of the biochemical, physiologic, and molecular effects of drugs on the human body, and it includes concepts such as receptor binding, post receptor effects, and chemical interactions. The study of pharmacodynamics is the second of two branches included in the scientific discipline of pharmacology. It is the quantitative investigation of the relationship between drug exposure and the drug's pharmacologic and effects. Pharmacodynamics refers to the relationship between drug concentration at the site of action and the resulting effect, which includes the time course and intensity of therapeutic and adverse effects.
Track 14: Pharmacoepidemiology
Pharmacoepidemiology is the study of medication utilisation and effects in large human populations, bridging clinical pharmacology and epidemiology. It calculates the risks and benefits of medication use on a variety of important physical and mental health outcomes. Pharmacoepidemiological studies are important for identifying rare but serious postmarketing adverse drug reactions. Investigating risks and benefits in populations excluded from randomized clinical trials; increasingly used in public health and clinical decisions.
Track 15: Pharmacogenomics
Pharmacogenomics (also known as pharmacogenetics) is the study of how a person's genes influence how he or she responds to medications. Its long-term goal is to assist doctors in selecting the drugs and dosages that are best suited for each individual. It falls under the purview of precision medicine, which seeks to treat each patient on an individual basis. The study of differential gene-expression profiles in tissues of interest and their relationship to drug-response phenotypes is referred to as pharmacogenomics. The field of pharmacogenomics is concerned with treatment efficacy, dosing, and safety. Pharmacogenomics is regarded as a critical future area for improving drug therapy and prescribing.
Track 16: Toxicology
Toxicology also referred to as “Science of Safety” is a practice that is being followed by the Pharmaceutical sectors around the world to identify the safety level of the chemical products or drugs before getting developed at a larger scale. The process of drug production involves using chemicals that are not familiar with the human system and are considered harmful. Toxicology studies analyse such drugs or chemicals and details the info regarding the potential uses or harms it may cause to the public. The toxicology process is essential in the process of drug development as even a minor increase in any of those chemical components will gravely affect the human system.
Track 17: Nutraceuticals
Nutraceuticals is an improving domain in the pharmaceutical sector in which the product (drug) is derived from the food sources thereby adding additional health benefits to the ones consuming and also improving the nutritional values of the individuals who are using such products. The products that are derived from the nutraceutical domain helps in maintaining a healthy human system, controlling any symptoms from diseases that may have arisen before and also prevent the system from having any malignant process in the system.
Track 18: Nano-surgery
The most recent uses of nanotechnology in the field of surgery are in the development of surgical implants using nanomaterials such as imaging, drug delivery, and tissue engineering products. Dental research has been conducted in the areas of nanotechnology and liposomal Collagenase-containing nanoparticles have been studied in rats and found to reduce collagen fibre more quickly than standard surgery, allowing teeth to move more easily with braces.
Track 19: Drug Discovery and Screening
Drug discovery is the process of finding novel drugs or medicines are discovered and aims to identify a compound therapeutically useful for treating and curing disease. It encompasses several different scientific fields, including as biology, chemistry, and pharmacology. One of the initial steps in the drug discovery process typically involves screening a large number of compounds to see if they have the desired biochemical or cellular effects. Methods to make this screening quicker, more efficient, and less expensive are constantly being developed.
The domain of Pharmaceutics is long and vast and we would like to welcome individuals from a wide array of sectors who we think can contribute and add some additional impudence to this conference.
The people who can attend this conference includes
Speakers can go through the below Mode of Participations
Oral presentation:
Oral sessions consist of a series of conversations with participants. The allotted time for each oral presentation is 20 minutes, followed by a 3-minute questionnaire.
Poster presentation:
Poster presentations allow you to interact face-to-face with people who are interested in your research. Posters should not be larger than A0.
Workshop presentation:
Workshop Talks are engaging, skills-based conversations that last up to 60 minutes. Workshops should be engaging and contain practical information that participants can bring back to the community.
Virtual presentation:
If you are unable to attend the conference but would like to present and publish your paper, we offer online presentations. Presentations are uploaded to the conference website prior to the conference. Abstracts must be submitted and authors must pay a registration fee. At the end of the conference, you will receive a certificate of presentation and a digital abstract book.
Reasons to attend Nanopharmaceutics 2022
Global Exposure:
The conference is set to be attended by some of the eminent and prominent researchers around the world. The topics that are to be discussed are otherworldly and your work and your presentation can also gain some positive influence among some of the researchers who are set to attend the event.
Industrial Exposure:
This conference is also to be represented by some of the leading pharmaceutical companies from around the world and their experience and their expertise will certainly influence the attendees who are going to participate on this conference.
Scientific Recognition:
NanoPharmaceutics 2022 is a landmark event which will provide chance for every researcher from around the world to showcase their work and their efforts that they have placed on their work on the past few months. NanoPharmaceutics 2022 is delighted to provide such tireless researchers a platform to shine and gain global and positive recognition among some of the major scientific professional in this domain
The marketing Evolution of the Pharmaceutical Sectors has considerably increased over this fiscal year due to the pandemic and increase in need for solutions to put an end what has been one of the economically worst hit years in past 10 years.
The global Nano medicine market is anticipated to grow from $221.12 billion in 2021 to $252.50 billion in 2022 at a compound annual rate of growth (CAGR) of 14.2%. The change in growth trend is principally because of the businesses beginning their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is approximated to succeed in $414.97 billion in 2026 at a CAGR of 13.2%.
Pfizer is one of the other major companies, who along with oxford university have developed a novel m-RNA based vaccine for the treatment of COVID-19 and was one of the first approved vaccine by WHO with an efficacy rate at 90%. It is also reported that the infection rate has considerably reduced to 65% in patients administered with this vaccine. With the complaints regarding the blood clot seems to not go away, the vaccine was proved to be effective and are administered considerably. They ended the financial year with a net profit of 41.9 million $, compared to their previous year which was in the region of 41.1 million $. It is reported that the increase in revenue might have to do with their swift production of Covid-19 Vaccine.
Johnson & Johnson is also another major player in the pharmaceutical sector, which have already developed a novel Covid-19 Vaccine for the treatment have been used throughout the US. Not in terms of Vaccine, Other medicinal products have also provided its fair share of Improvement in increasing the revenue for this commercial giant. It is reported that based on the medicinal sales alone, they have generated a total revenue of 45 million$ compared to that of their previous year’s sales with was at 42 million$.
The Moderna is a startup which was only founded on the year of 2010 and to achieve the level of revenue that they have improved over the period of time is a testament to their continuous hard work and the commitment that they have shown to the society.
